386 related articles for article (PubMed ID: 31949051)
1. VISTA is a checkpoint regulator for naïve T cell quiescence and peripheral tolerance.
ElTanbouly MA; Zhao Y; Nowak E; Li J; Schaafsma E; Le Mercier I; Ceeraz S; Lines JL; Peng C; Carriere C; Huang X; Day M; Koehn B; Lee SW; Silva Morales M; Hogquist KA; Jameson SC; Mueller D; Rothstein J; Blazar BR; Cheng C; Noelle RJ
Science; 2020 Jan; 367(6475):. PubMed ID: 31949051
[TBL] [Abstract][Full Text] [Related]
2. VISTA is an immune checkpoint molecule for human T cells.
Lines JL; Pantazi E; Mak J; Sempere LF; Wang L; O'Connell S; Ceeraz S; Suriawinata AA; Yan S; Ernstoff MS; Noelle R
Cancer Res; 2014 Apr; 74(7):1924-32. PubMed ID: 24691993
[TBL] [Abstract][Full Text] [Related]
3. Immune-checkpoint proteins VISTA and PD-1 nonredundantly regulate murine T-cell responses.
Liu J; Yuan Y; Chen W; Putra J; Suriawinata AA; Schenk AD; Miller HE; Guleria I; Barth RJ; Huang YH; Wang L
Proc Natl Acad Sci U S A; 2015 May; 112(21):6682-7. PubMed ID: 25964334
[TBL] [Abstract][Full Text] [Related]
4. Disruption of the immune-checkpoint VISTA gene imparts a proinflammatory phenotype with predisposition to the development of autoimmunity.
Wang L; Le Mercier I; Putra J; Chen W; Liu J; Schenk AD; Nowak EC; Suriawinata AA; Li J; Noelle RJ
Proc Natl Acad Sci U S A; 2014 Oct; 111(41):14846-51. PubMed ID: 25267631
[TBL] [Abstract][Full Text] [Related]
5. VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses.
Wang L; Rubinstein R; Lines JL; Wasiuk A; Ahonen C; Guo Y; Lu LF; Gondek D; Wang Y; Fava RA; Fiser A; Almo S; Noelle RJ
J Exp Med; 2011 Mar; 208(3):577-92. PubMed ID: 21383057
[TBL] [Abstract][Full Text] [Related]
6. VISTA Regulates the Development of Protective Antitumor Immunity.
Le Mercier I; Chen W; Lines JL; Day M; Li J; Sergent P; Noelle RJ; Wang L
Cancer Res; 2014 Apr; 74(7):1933-44. PubMed ID: 24691994
[TBL] [Abstract][Full Text] [Related]
7. High-Affinity Anti-VISTA Antibody Protects against Sepsis by Inhibition of T Lymphocyte Apoptosis and Suppression of the Inflammatory Response.
Tao T; Bo L; Li T; Shi L; Zhang H; Ye B; Xu Y; Ma Q; Deng X; Zhang G
Mediators Inflamm; 2021; 2021():6650329. PubMed ID: 34366711
[TBL] [Abstract][Full Text] [Related]
8. Targeting the V-Type Immunoglobulin Domain-Containing Suppressor to T Cell Activation (VISTA) with Agonist Monoclonal Antibodies in Autoimmunity.
Jung M; Bonavida B
Crit Rev Immunol; 2022; 42(4):37-49. PubMed ID: 37022358
[TBL] [Abstract][Full Text] [Related]
9. VISTA regulates microglia homeostasis and myelin phagocytosis, and is associated with MS lesion pathology.
Borggrewe M; Kooistra SM; Wesseling EM; Gierschek FL; Brummer ML; Nowak EC; Medeiros-Furquim T; Otto TA; Lee SW; Noelle RJ; Eggen BJL; Laman JD
Acta Neuropathol Commun; 2021 May; 9(1):91. PubMed ID: 34006329
[TBL] [Abstract][Full Text] [Related]
10. An engineered antibody binds a distinct epitope and is a potent inhibitor of murine and human VISTA.
Mehta N; Maddineni S; Kelly RL; Lee RB; Hunter SA; Silberstein JL; Parra Sperberg RA; Miller CL; Rabe A; Labanieh L; Cochran JR
Sci Rep; 2020 Sep; 10(1):15171. PubMed ID: 32938950
[TBL] [Abstract][Full Text] [Related]
11. Exploring the VISTA of microglia: immune checkpoints in CNS inflammation.
Borggrewe M; Kooistra SM; Noelle RJ; Eggen BJL; Laman JD
J Mol Med (Berl); 2020 Oct; 98(10):1415-1430. PubMed ID: 32856125
[TBL] [Abstract][Full Text] [Related]
12. VISTA nonredundantly regulates proliferation and CD69low γδ T cell accumulation in the intestine in murine sepsis.
Gray CC; Armstead BE; Chung CS; Chen Y; Ayala A
J Leukoc Biol; 2024 May; 115(6):1005-1019. PubMed ID: 38035776
[TBL] [Abstract][Full Text] [Related]
13. Defining the Signature of VISTA on Myeloid Cell Chemokine Responsiveness.
Broughton TWK; ElTanbouly MA; Schaafsma E; Deng J; Sarde A; Croteau W; Li J; Nowak EC; Mabaera R; Smits NC; Kuta A; Noelle RJ; Lines JL
Front Immunol; 2019; 10():2641. PubMed ID: 31803182
[TBL] [Abstract][Full Text] [Related]
14. Immune-checkpoint protein VISTA in allergic, autoimmune disease and transplant rejection.
Zheng M; Zhang Z; Yu L; Wang Z; Dong Y; Tong A; Yang H
Front Immunol; 2023; 14():1194421. PubMed ID: 37435070
[TBL] [Abstract][Full Text] [Related]
15. VISTA deficiency attenuates antibody-induced arthritis and alters macrophage gene expression in response to simulated immune complexes.
Ceeraz S; Eszterhas SK; Sergent PA; Armstrong DA; Ashare A; Broughton T; Wang L; Pechenick D; Burns CM; Noelle RJ; Vincenti MP; Fava RA
Arthritis Res Ther; 2017 Dec; 19(1):270. PubMed ID: 29216931
[TBL] [Abstract][Full Text] [Related]
16. VSIG-3 as a ligand of VISTA inhibits human T-cell function.
Wang J; Wu G; Manick B; Hernandez V; Renelt M; Erickson C; Guan J; Singh R; Rollins S; Solorz A; Bi M; Li J; Grabowski D; Dirkx J; Tracy C; Stuart T; Ellinghuysen C; Desmond D; Foster C; Kalabokis V
Immunology; 2019 Jan; 156(1):74-85. PubMed ID: 30220083
[TBL] [Abstract][Full Text] [Related]
17. VISTA Re-programs Macrophage Biology Through the Combined Regulation of Tolerance and Anti-inflammatory Pathways.
ElTanbouly MA; Schaafsma E; Smits NC; Shah P; Cheng C; Burns C; Blazar BR; Noelle RJ; Mabaera R
Front Immunol; 2020; 11():580187. PubMed ID: 33178206
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-Induced VISTA Promotes the Suppressive Function of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment.
Deng J; Li J; Sarde A; Lines JL; Lee YC; Qian DC; Pechenick DA; Manivanh R; Le Mercier I; Lowrey CH; Varn FS; Cheng C; Leib DA; Noelle RJ; Mabaera R
Cancer Immunol Res; 2019 Jul; 7(7):1079-1090. PubMed ID: 31088847
[TBL] [Abstract][Full Text] [Related]
19. LRIG1 engages ligand VISTA and impairs tumor-specific CD8
Ta HM; Roy D; Zhang K; Alban T; Juric I; Dong J; Parthasarathy PB; Patnaik S; Delaney E; Gilmour C; Zakeri A; Shukla N; Rupani A; Phoon YP; Liu C; Avril S; Gastman B; Chan T; Wang LL
Sci Immunol; 2024 May; 9(95):eadi7418. PubMed ID: 38758807
[TBL] [Abstract][Full Text] [Related]
20. VISTA Targeting of T-cell Quiescence and Myeloid Suppression Overcomes Adaptive Resistance.
Schaafsma E; Croteau W; ElTanbouly M; Nowak EC; Smits NC; Deng J; Sarde A; Webber CA; Rabadi D; Cheng C; Noelle R; Lines JL
Cancer Immunol Res; 2023 Jan; 11(1):38-55. PubMed ID: 36260656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
